WARNING: “Buffett Indicator” flashing for first time in 50 years

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

Nello Mainolfi Biography and Net Worth

CEO of Kymera Therapeutics

Nello started his drug discovery career at the Novartis Institutes for Biomedical Research, leading teams to identify multiple novel potential medicines that have entered clinical development across a series of disease areas. Notably he led the team that discovered and developed the first complement factor B inhibitor now in late clinical development across a range of indications. Before founding Kymera, Mainolfi was an Entrepreneur in Residence at Atlas Venture and had previously led discovery research at cancer metabolism startup Raze Therapeutics. Nello has authored >60 papers and patents and has written reviews in the areas of medicinal chemistry, drug discovery and protein degradation. Nello was trained at Imperial College, University of London and The Scripps Research Institute in California.

What is Nello Mainolfi's net worth?: The estimated net worth of Nello Mainolfi is at least $18.62 million as of August 4th, 2021. Dr. Mainolfi owns 457,868 shares of Kymera Therapeutics stock worth more than $18,616,913 as of December 21st. This net worth estimate does not reflect any other assets that Dr. Mainolfi may own. Additionally, Dr. Mainolfi receives a salary of $1,080,000.00 as CEO at Kymera Therapeutics. Learn More about Nello Mainolfi's net worth.
How old is Nello Mainolfi?: Dr. Mainolfi is currently 45 years old. There are 4 older executives and no younger executives at Kymera Therapeutics. Learn More on Nello Mainolfi's age.
What is Nello Mainolfi's salary?: As the CEO of Kymera Therapeutics, Inc., Dr. Mainolfi earns $1,080,000.00 per year. Learn More on Nello Mainolfi's salary.
How do I contact Nello Mainolfi?: The corporate mailing address for Dr. Mainolfi and other Kymera Therapeutics executives is 200 Arsenal Yards Blvd. Suite 230, Watertown MA, 02472. Kymera Therapeutics can also be reached via phone at 857-285-5300 and via email at [email protected]. Learn More on Nello Mainolfi's contact information.
Has Nello Mainolfi been buying or selling shares of Kymera Therapeutics?: Nello Mainolfi has not been actively trading shares of Kymera Therapeutics during the past quarter. Most recently, Nello Mainolfi sold 8,612 shares of the business's stock in a transaction on Wednesday, January 12th. The shares were sold at an average price of $52.08, for a transaction totalling $448,512.96. Learn More on Nello Mainolfi's trading history.
Who are Kymera Therapeutics' active insiders?: Kymera Therapeutics' insider roster includes Jeffrey Albers (Director), Bruce Booth (Director), Richard Chesworth (Insider), Ellen Chiniara (Chief Legal Officer and Corporate Secretary), Jared Gollob (Insider), Bruce Jacobs (CFO), and Nello Mainolfi (CEO). Learn More on Kymera Therapeutics' active insiders.
Are insiders buying or selling shares of Kymera Therapeutics?: In the last twelve months, insiders at the sold shares 16 times. They sold a total of 1,008,191 shares worth more than $40,176,324.03. The most recent insider tranaction occured on September, 17th when Director Pamela Esposito sold 13,500 shares worth more than $651,780.00. Insiders at Kymera Therapeutics own 15.8% of the company. Learn More about insider trades at Kymera Therapeutics.
Information on this page was last updated on 9/17/2024.

Nello Mainolfi Insider Trading History at Kymera Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/12/2022	Sell	8,612	$52.08	$448,512.96
1/10/2022	Sell	22,465	$53.26	$1,196,485.90
10/11/2021	Sell	6,456	$53.68	$346,558.08
10/8/2021	Sell	41,544	$56.76	$2,358,037.44
8/4/2021	Sell	1,037	$60.03	$62,251.11	457,868
8/2/2021	Sell	23,456	$60.30	$1,414,396.80	452,879
7/30/2021	Sell	6,279	$60.07	$377,179.53
7/28/2021	Sell	3,864	$60.15	$232,419.60	461,214
7/26/2021	Sell	9,015	$60.15	$542,252.25	461,214
7/8/2021	Sell	48,000	$49.70	$2,385,600.00	500,199
6/9/2021	Sell	5,752	$50.02	$287,715.04	424,923
6/7/2021	Sell	12,724	$50.14	$637,981.36	424,923
5/12/2021	Sell	8,245	$50.05	$412,662.25	405,444
4/26/2021	Sell	2,768	$40.18	$111,218.24	408,158
4/23/2021	Sell	680	$40.01	$27,206.80	408,158
4/19/2021	Sell	653	$40.00	$26,120.00	396,139
4/15/2021	Sell	4,940	$40.29	$199,032.60	396,139
4/12/2021	Sell	15,267	$32.62	$498,009.54	386,138
4/9/2021	Sell	22,794	$33.68	$767,701.92	386,138

Nello Mainolfi Buying and Selling Activity at Kymera Therapeutics

Kymera Therapeutics Company Overview

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company develops STAT6, a Type 2 inflammation in allergic diseases; and TYK2, a treatment for inflammatory bowel disease, psoriasis, psoriatic arthritis, and lupus. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $40.66

$38.24

$40.78

50 Day Range

MA: $46.00

$39.06

$51.84

2 Week Range

Now: $40.66

$22.35

$53.27

Volume

1,145,939 shs

Average Volume

582,401 shs

Market Capitalization

$2.63 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.16

WARNING: “Buffett Indicator” flashing for first time in 50 years

From Behind the Markets | Ad

Take these 4 steps today to protect your retirement NOW

Nello Mainolfi Biography and Net Worth

What is Nello Mainolfi's net worth?

How old is Nello Mainolfi?

What is Nello Mainolfi's salary?

How do I contact Nello Mainolfi?

Has Nello Mainolfi been buying or selling shares of Kymera Therapeutics?

Who are Kymera Therapeutics' active insiders?

Are insiders buying or selling shares of Kymera Therapeutics?